Loading...
PetMed Express, Inc.
PETS•NASDAQ
HealthcareMedical - Pharmaceuticals
$3.96
$-0.01(-0.25%)
PetMed Express, Inc. (PETS) Financial Performance & Statements
Review PetMed Express, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
9.42%
↑ 9.42%
Operating Income Growth
-470.77%
↓ 470.77%
Net Income Growth
-3303.43%
↓ 3303.43%
Operating Cash Flow Growth
-84.47%
↓ 84.47%
Operating Margin
0.22%
↑ 0.22%
Gross Margin
26.21%
↑ 26.21%
Net Profit Margin
0.14%
↑ 0.14%
ROE
0.37%
↑ 0.37%
ROIC
0.57%
↑ 0.57%
PetMed Express, Inc. (PETS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for PetMed Express, Inc. stock.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $52.98M | $59.57M | $67.95M | $66.50M |
| Cost of Revenue | $38.08M | $42.26M | $51.70M | $50.22M |
| Gross Profit | $14.91M | $17.31M | $16.25M | $16.28M |
| Gross Profit Ratio | $0.28 | $0.29 | $0.24 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $13.77M | $15.10M | $11.86M | $20.22M |
| Operating Expenses | $15.36M | $16.76M | $11.86M | $20.22M |
| Total Costs & Expenses | $53.43M | $59.02M | $63.57M | $70.44M |
| Interest Income | $28000.00 | $185000.00 | $95000.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $30000.00 |
| Depreciation & Amortization | $1.59M | $1.66M | $1.72M | $1.90M |
| EBITDA | $1.14M | $2.21M | $6.11M | -$1.58M |
| EBITDA Ratio | $0.02 | $0.04 | $0.09 | -$0.03 |
| Operating Income | -$450000.00 | $554000.00 | $4.39M | -$3.94M |
| Operating Income Ratio | -$0.008 | $0.009 | $0.06 | -$0.06 |
| Other Income/Expenses (Net) | $208000.00 | $371000.00 | $326000.00 | $355000.00 |
| Income Before Tax | -$242000.00 | $925000.00 | $4.71M | -$3.48M |
| Income Before Tax Ratio | -$0.005 | $0.02 | $0.07 | -$0.05 |
| Income Tax Expense | $465000.00 | -$1.40M | $958000.00 | $1.54M |
| Net Income | -$707000.00 | $2.33M | $3.75M | -$5.02M |
| Net Income Ratio | -$0.01 | $0.04 | $0.06 | -$0.08 |
| EPS | -$0.03 | $0.11 | $0.18 | -$0.25 |
| Diluted EPS | -$0.03 | $0.11 | $0.18 | -$0.25 |
| Weighted Avg Shares Outstanding | $20.63M | $20.60M | $20.51M | $20.44M |
| Weighted Avg Shares Outstanding (Diluted) | $20.63M | $20.94M | $20.94M | $20.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan